<DOC>
	<DOC>NCT03026257</DOC>
	<brief_summary>The purpose of this study is to evaluate worn AIR OPTIX® plus HYDRAGLYDE® (AOHG) lenses cleaned and disinfected with HYDRAGLYDE® containing lens solutions compared to each of the control habitual silicone hydrogel (SiHy) lenses cleaned and disinfected with habitual multi-purpose solution (MPS) for cholesterol uptake.</brief_summary>
	<brief_title>Clinical Assessment of a HYDRAGLYDE® Regimen</brief_title>
	<detailed_description />
	<mesh_term>Refractive Errors</mesh_term>
	<mesh_term>Hyperopia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Contact Lens Solutions</mesh_term>
	<mesh_term>Hydrogen Peroxide</mesh_term>
	<criteria>Must sign informed consent document; Vision correctable to 0.1 (LogMAR) or better in each eye at distance with habitual lenses; Manifest cylinder (at screening) less than or equal to 0.75 diopter (D) in each eye and spectacle add &lt;+0.50 D in each eye; Current fulltime wearer of spherical samfilcon A, comfilcon A, senofilcon C monthly or senofilcon A 2week replacement lens within the power range of lens powers available; Current user of an MPS (excluding OFPM) to care for lenses; Willing to answer text messages on a daily basis during the study; Willing to discontinue artificial tears during the study and rewetting drops on the days of study visits; Use of digital devices (eg, smart phone, tablet, laptop or desktop computer) for 20 consecutive minutes at least twice a week and willing to continue for the duration of the study; Other protocol specific inclusion criteria may apply. Habitual lens wear in an extended wear modality (routinely sleeping in lenses overnight for 1 or more nights per week); Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear; History of herpetic keratitis, corneal surgery or irregular cornea; Prior refractive surgery; Any use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator; Currently using or have not discontinued Restasis®, XiidraTM and/or topical steroids within the past 7 days; Use of mechanical eyelid therapy or eyelid scrubs within 14 days before Visit 1 and not willing to discontinue during the study; Monocular (only 1 eye with functional vision) or fit with only 1 lens; Known pregnancy or lactating; Other protocol specific exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>